Boundless Bio, Inc. Common Stock (BOLD) — Long-term Investment Intensity
Boundless Bio, Inc. Common Stock (BOLD) has a Long-term Investment Intensity of 30.8% as of December 2021. Long-term investments of $34.99 Million represent 30.8% of total assets of $113.72 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Boundless Bio, Inc. Common Stock liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Boundless Bio, Inc. Common Stock Long-term Investment Intensity (2021–2021)
This chart shows how Boundless Bio, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of December 2021, the intensity stands at 30.8%, reflecting long-term investments of $34.99 Million against total assets of $113.72 Million USD. For the complete balance sheet picture, see Boundless Bio, Inc. Common Stock assets under control.
Annual Long-term Investment Intensity for Boundless Bio, Inc. Common Stock (2021–2021)
The table below presents the year-by-year Long-term Investment Intensity for Boundless Bio, Inc. Common Stock from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read BOLD total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 30.8% | $34.99 Million | $113.72 Million | — |